September 21, 2018 - Fierce Biotech
Agenus has sold a portion of the royalties and milestones it is due to receive from Incyte and Merck. Xoma is paying $15 million for one-third of the $600 million in milestones Agenus is in line to pocket and a 10% cut of any royalties.
September 20, 2018 - Reuters
The US$5.05bn term loan for Envision Healthcare is the third massive leveraged loan to hit the market since September and also looks set to benefit from huge institutional demand which has already seen multibillion buyout loans for Thomson Reuters' F&R business, Refinitiv, and Akzo Nobel's Specialty Chemicals business successfully placed.
September 20, 2018 - Bio Space
Shares of Molecular Templates are up more than 52 percent in premarket trading after the company announced it has struck a deal with pharma giant Takeda Pharmaceuticals that could be worth up to $632 million to develop CD38-targeted engineered toxin bodies (ETBs).
|